D'Agata Erika M C, Dupont-Rouzeyrol Myrielle, Magal Pierre, Olivier Damien, Ruan Shigui
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
PLoS One. 2008;3(12):e4036. doi: 10.1371/journal.pone.0004036. Epub 2008 Dec 29.
The emergence and ongoing spread of antimicrobial-resistant bacteria is a major public health threat. Infections caused by antimicrobial-resistant bacteria are associated with substantially higher rates of morbidity and mortality compared to infections caused by antimicrobial-susceptible bacteria. The emergence and spread of these bacteria is complex and requires incorporating numerous interrelated factors which clinical studies cannot adequately address.
METHODS/PRINCIPAL FINDINGS: A model is created which incorporates several key factors contributing to the emergence and spread of resistant bacteria including the effects of the immune system, acquisition of resistance genes and antimicrobial exposure. The model identifies key strategies which would limit the emergence of antimicrobial-resistant bacterial strains. Specifically, the simulations show that early initiation of antimicrobial therapy and combination therapy with two antibiotics prevents the emergence of resistant bacteria, whereas shorter courses of therapy and sequential administration of antibiotics promote the emergence of resistant strains.
CONCLUSIONS/SIGNIFICANCE: The principal findings suggest that (i) shorter lengths of antibiotic therapy and early interruption of antibiotic therapy provide an advantage for the resistant strains, (ii) combination therapy with two antibiotics prevents the emergence of resistance strains in contrast to sequential antibiotic therapy, and (iii) early initiation of antibiotics is among the most important factors preventing the emergence of resistant strains. These findings provide new insights into strategies aimed at optimizing the administration of antimicrobials for the treatment of infections and the prevention of the emergence of antimicrobial resistance.
抗菌药物耐药细菌的出现和持续传播是对公共卫生的重大威胁。与抗菌药物敏感细菌引起的感染相比,抗菌药物耐药细菌引起的感染与更高的发病率和死亡率相关。这些细菌的出现和传播很复杂,需要纳入众多相互关联的因素,而临床研究无法充分解决这些问题。
方法/主要发现:构建了一个模型,该模型纳入了导致耐药细菌出现和传播的几个关键因素,包括免疫系统的影响、耐药基因的获得和抗菌药物暴露。该模型确定了可限制抗菌药物耐药菌株出现的关键策略。具体而言,模拟结果表明,早期开始抗菌治疗以及两种抗生素联合治疗可防止耐药细菌的出现,而较短疗程的治疗和抗生素序贯给药则会促进耐药菌株的出现。
结论/意义:主要发现表明,(i)较短的抗生素治疗疗程和早期中断抗生素治疗有利于耐药菌株,(ii)与抗生素序贯治疗相比,两种抗生素联合治疗可防止耐药菌株的出现,(iii)早期开始使用抗生素是防止耐药菌株出现的最重要因素之一。这些发现为旨在优化抗菌药物给药以治疗感染和预防抗菌药物耐药性出现的策略提供了新的见解。